{"id":"https://openalex.org/W1980631925","doi":"https://doi.org/10.2174/138161208784705432","title":"The Blood-Central Nervous System Barriers Actively Control Immune Cell Entry into the Central Nervous System","display_name":"The Blood-Central Nervous System Barriers Actively Control Immune Cell Entry into the Central Nervous System","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-01","ids":{"openalex":"https://openalex.org/W1980631925","doi":"https://doi.org/10.2174/138161208784705432","mag":"1980631925","pmid":"https://pubmed.ncbi.nlm.nih.gov/18673197"},"language":"en","primary_location":{"id":"doi:10.2174/138161208784705432","doi":"https://doi.org/10.2174/138161208784705432","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161208784705432","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1980631925"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069271331","display_name":"Britta Engelhardt","orcid":"https://orcid.org/0000-0003-3059-9846","observed_orcids":["https://orcid.org/0000-0003-3059-9846"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Britta Engelhardt","raw_affiliation_strings":["Theodor Kocher Institute, University of Bern, Freiestr. 1, CH-3012 Bern, Switzerland. bengel@tki.unibe.ch","Theodor Kocher Institute, University of Bern, Freiestr. 1, CH-3012 Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theodor Kocher Institute, University of Bern, Freiestr. 1, CH-3012 Bern, Switzerland. bengel@tki.unibe.ch","institution_ids":["https://openalex.org/I118564535"]},{"raw_affiliation_string":"Theodor Kocher Institute, University of Bern, Freiestr. 1, CH-3012 Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069271331"],"corresponding_institution_ids":["https://openalex.org/I118564535"],"apc_list":null,"apc_paid":null,"fwci":8.078,"has_fulltext":false,"cited_by_count":169,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97961551,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"14","issue":"16","first_page":"1555","last_page":"1565"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8870000243186951},{"id":"https://openalex.org/keywords/blood-cerebrospinal-fluid-barrier","display_name":"blood-CSF barrier","score":0.9559999704360962},{"id":"https://openalex.org/keywords/circumventricular-organs","display_name":"circumventricular organs","score":0.9789999723434448},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis","display_name":"experimental autoimmune encephalomyelitis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/integrin-alpha4","display_name":"CD49d","score":0.8029999732971191},{"id":"https://openalex.org/keywords/leukocyte-migration","display_name":"leukocyte migration","score":0.9580000042915344},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7616698741912842},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.6993719339370728},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.6781275868415833},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.6718133687973022},{"id":"https://openalex.org/C2778486448","wikidata":"https://www.wikidata.org/wiki/Q494066","display_name":"Experimental autoimmune encephalomyelitis","level":3,"score":0.6223983764648438},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.5737635493278503},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5112364292144775},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4985771179199219},{"id":"https://openalex.org/C201934248","wikidata":"https://www.wikidata.org/wiki/Q2492999","display_name":"Neuroimmunology","level":3,"score":0.4416203200817108},{"id":"https://openalex.org/C2910341952","wikidata":"https://www.wikidata.org/wiki/Q570425","display_name":"Leukocyte Trafficking","level":4,"score":0.41150087118148804},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3451085090637207},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.34410974383354187},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.09726983308792114}],"mesh":[{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002464","descriptor_name":"Cell Migration Inhibition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002490","descriptor_name":"Central Nervous System","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002490","descriptor_name":"Central Nervous System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002555","descriptor_name":"Cerebrospinal Fluid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002634","descriptor_name":"Chemotaxis, Leukocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004681","descriptor_name":"Encephalomyelitis, Autoimmune, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004681","descriptor_name":"Encephalomyelitis, Autoimmune, Experimental","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004681","descriptor_name":"Encephalomyelitis, Autoimmune, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017951","descriptor_name":"Antigen Presentation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D039441","descriptor_name":"Integrin alpha4","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/138161208784705432","doi":"https://doi.org/10.2174/138161208784705432","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161208784705432","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:18673197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18673197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"},{"id":"pmh:oai:boris.unibe.ch:28192","doi":null,"is_oa":false,"landing_page_url":"https://boris.unibe.ch/28192/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401747","display_name":"BORIS (University Library Bern)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210103840","host_organization_name":"Nakuru County Council","host_organization_lineage":["https://openalex.org/I4210103840"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Engelhardt, Britta (2008). The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Current pharmaceutical design, 14(16), pp. 1555-65. Hilversum: Bentham Science Publishers 10.2174/138161208784705432 &lt;http://dx.doi.org/10.2174/138161208784705432&gt;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2140686375","https://openalex.org/W79943469","https://openalex.org/W2118254660","https://openalex.org/W1980288403","https://openalex.org/W2055950044","https://openalex.org/W6940393509","https://openalex.org/W4213258650","https://openalex.org/W1980680096","https://openalex.org/W2737631699","https://openalex.org/W2003678892"],"abstract_inverted_index":{"Before":[0],"entering":[1],"the":[2,19,23,29,33,42,52,58,67,86,109,118,122,134,139,146,160,163,166,190,204,210,233,238,242],"central":[3],"nervous":[4],"system":[5],"(CNS)":[6],"immune":[7,114,156,186,200,229],"cells":[8,65,82],"have":[9,102],"to":[10,85,105,133,138,159,178,185],"penetrate":[11],"any":[12],"one":[13],"of":[14,37,46,54,60,80,108,141,148,168,199,241],"its":[15],"barriers,":[16],"namely":[17],"either":[18],"endothelial":[20],"blood-brain":[21],"barrier,":[22],"epithelial":[24],"blood-cerebrospinal":[25],"fluid":[26],"barrier":[27,31,224],"or":[28],"tanycytic":[30],"around":[32],"circumventricular":[34],"organs,":[35],"all":[36],"which":[38,152],"maintain":[39],"homeostasis":[40],"within":[41],"CNS.":[43,119,161],"The":[44,196],"presence":[45],"these":[47],"barriers":[48,212,244],"in":[49,91,113,130,174],"combination":[50],"with":[51],"lack":[53],"lymphatic":[55],"vessels":[56],"and":[57,171,181],"absence":[59],"classical":[61],"MHC-positive":[62],"antigen":[63],"presenting":[64],"characterizes":[66],"CNS":[68,87,135,191,205,234,246],"as":[69],"an":[70],"immunologically":[71],"privileged":[72],"site.":[73],"In":[74,120],"multiple":[75,100,150],"sclerosis":[76],"a":[77,96,127,142],"large":[78],"number":[79],"inflammatory":[81],"gains":[83],"access":[84],"parenchyma.":[88],"Studies":[89],"performed":[90],"experimental":[92],"autoimmune":[93],"encephalomyelitis":[94],"(EAE),":[95],"rodent":[97],"model":[98],"for":[99,145],"sclerosis,":[101,151],"enabled":[103],"us":[104],"understand":[106],"some":[107,223],"molecular":[110],"mechanisms":[111],"involved":[112],"cell":[115,157,187,201,230],"entry":[116,188,231],"into":[117,189,203,232],"particular,":[121],"realization":[123],"that":[124],"/alpha4-integrins":[125],"play":[126],"predominant":[128],"role":[129],"leukocyte":[131],"trafficking":[132,202],"has":[136],"led":[137],"development":[140],"novel":[143,182],"drug":[144],"treatment":[147],"relapsing-remitting":[149],"targets":[153],"/alpha4-integrin":[154],"mediated":[155],"migration":[158],"At":[162],"same":[164],"time,":[165],"involvement":[167],"other":[169],"adhesion":[170],"signalling":[172],"molecules":[173,183],"this":[175],"process":[176,198],"remains":[177],"be":[179],"investigated":[180],"contributing":[184],"are":[192,226],"still":[193],"being":[194],"identified.":[195],"entire":[197],"is":[206],"strictly":[207],"controlled":[208],"by":[209],"brain":[211,243],"not":[213],"only":[214],"under":[215],"physiological":[216],"conditions":[217],"but":[218],"also":[219],"during":[220],"neuroinflammation,":[221],"when":[222],"properties":[225],"lost.":[227],"Thus,":[228],"critically":[235],"depends":[236],"on":[237],"unique":[239],"characteristics":[240],"maintaining":[245],"homeostasis.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1980631925","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
